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Common neurological 
complications of untreated 
Graves’ disease include 
cognitive dysfunction, tremor, 
ophthalmopathy, myopathy 
and polyneuropathy. Myasthenia gravis and 
seizures are uncommon associations, while 
thyrotoxic periodic paralysis, stroke and 
chorea occur only rarely.[1]
We present a patient with Graves’ disease 
and the acute motor axonal neuropathy 
(AMAN) variant of Guillain-Barré syndrome, 
which masqueraded as so-called Basedow 
paraplegia.[1-5] Had the diagnosis of Basedow 
paraplegia been adhered to, the patient would 
have been denied the opportunity of receiving 
gammaglobulin therapy.
Case report
An 18-year-old female was admitted 
in November 2014 with acute onset of 
severe global leg and arm weakness that 
had started 4 days before her admission. 
There was a background history (over the 
previous 11 months) of proptosis, dysp-
noea on exertion, palpitations, irritability 
and forgetfulness. General examination 
revealed tachycardia and a symmetrical 
diffusely enlarged goitre. Proptosis and 
lid lag were also present. Neurological 
examination revealed motor weakness, 
with her legs more affected than her 
arms. There was global hypotonia and 
deep tendon areflexia, with sparing of all 
sensory modalities. Blood tests confirmed 
the clinical suspicion of hyperthyroidism. 
Serum potassium levels were repeatedly 
normal (Table 1), urine porphobilinogen 
screening was negative and antiganglioside 
antibodies were absent.
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Thyrotoxic myopathy frequently occurs in clinical practice; however, the association of hyperthyroidism with a flaccid, areflexic paraplegia, 
so-called Basedow paraplegia, appears to represent a controversial and doubtful entity.
An 18-year-old female with undiagnosed and untreated Graves’ disease presented with acute onset of global weakness predominantly 
in the lower limbs, but also affecting the upper limbs. The weakness was accompanied by hypotonia and areflexia. Clinically, the patient 
had a goitre and signs of thyroid ocular disease. Laboratory testing confirmed the presence of hyperthyroidism, and thyroid-stimulating 
hormone receptor antibodies were positive. The cerebrospinal fluid protein level was raised. The electroneuronographic and needle 
examinations were compatible with a clear denervation process, such as acute motor axonal neuropathy, a variant of Guillain-Barré 
syndrome. Intravenous immunoglobulin therapy, carbimazole and propranolol were administered.
The occurrence of hyperthyroidism with a flaccid, areflexic paraplegia appears to represent more of a fortuitous than a causative 
association. It is important to consider and treat other causes, such as acute idiopathic polyneuritis.
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Table 1. Laboratory results
On admission
1 week after 
admission
2 weeks after 
admission
TSH (mIU/L) (0.48 - 4.26) 0.08
Free thyroxine (pmol/L) (7.6 - 16.1) 55 30.4 27.5
Potassium (mmol/L) (3.5 - 5.1) 4.9 4.0
TSH receptor antibody (U/L) (<1.75) 36.26
Cerebrospinal fluid protein (g/L) 
(0.15 - 0.45)
0.86
TSH = thyroid-stimulating hormone.
Table 2. Electroneuronographic study, 11 November 2014
Motor nerve responses Sensory nerve responses
Nerve Muscle
CMAP 
amplitude
Normal 
values
Peak 
latency
SNAP 
amplitude
Normal 
value
R median APB 2.6 mV >4.0 mV Palmar 50.7 µV >50 µV
R ulnar ADM 530 µV >6 mV Palmar 34.5 µV >15 µV
R peroneal EDB 127 µV >2 mV
R tibial AH 1.7 mV >4 mV
R sural Point B 24.0 µV >6 µV
R = right; CMAP = compound muscle action potential; SNAP = sensory nerve action potential; APB = abductor pollicis brevis; 
ADM = abductor digiti minimi; EDB = extensor digitorum brevis; AH = abductor hallices. The R median, ulnar, peroneal and 
tibial nerve latencies were 2.8 ms, 2.4 ms, 3.0 ms and 3.5 ms, respectively (within normal limits), and their conduction velocities 
54.4 m/s, 70.3 m/s, 43.4 m/s and 55.3 m/s, respectively, were also normal. The sensory peak latencies of the R median (palmar), 
R ulnar (palmar) and R sural (point B) nerves were 1.9 ms, 2.0 ms and 3.3 ms, respectively (within normal limits), and their 
conduction velocities 56.3 m/s, 51.3 m/s and 51.5 m/s, respectively (within normal limits).
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The electroneuronographic studies of 11 
and 25 November 2014 showed significantly 
decreased compound muscle action potential 
(CMAP) amplitudes and preserved sensory 
nerve action potential (SNAP) amplitudes, 
with normal distal latencies and conduction 
velocities, favouring a diagnosis of an AMAN 
variant of the Guillain-Barré syndrome 
(Tables 2 and 3). Needle examination of the 
tibialis anterior muscle on 25 November 2014 
showed the presence of fibrillation potentials 
and clear neurogenic polyphasic motor units.
A 5-day course of intravenous immuno-
globulins, 24 g/day, was admin istered. 
Carbimazole was prescribed at 20  mg 
8-hourly, and on the development of a skin 
reaction the dose was decreased to 10  mg 
8-hourly. Propranonol was administered at 
a dose of 20 mg 6-hourly. The thyrotoxicosis 
gradually improved, but the patient’s 
neurological condition had only marginally 
improved at the time of discharge.
Discussion
Joffroy coined the term Basedow paraplegia 
in 1894, after Charcot had referred to 
‘paraplegia like weakness’ in severe hyper-
thyroidism in 1889.[3] Joffroy went on to 
describe the concept as follows: ‘A flaccid 
paraplegia with absent reflexes, minimal 
or no sensory disturbance, and absent 
sphincter disturbances,’[3] which Pandit 
in 1998 commented ‘could very well fit 
the description of acute post infective 
polyneuritis’.[3] Feibel and Campa[2] used 
the term ‘thyrotoxic neuropathy (Basedow 
paraplegia)’ in 1976 and Pandit,[3] in 
1998, published a report ‘Acute thyrotoxic 
neuropathy – Basedow’s paraplegia revisited,’ 
with the suggestion of an implicit causal 
relationship between the hyperthyroidism 
and the neuropathy. However, on closer 
scrutiny this association may well be 
fortuitous.
Descriptions of Basedow paraplegia[1-5] 
appear to conform to the development of 
an ‘acute flaccid paraplegia with absent 
reflexes’ against the background of hyper-
thyroidism. It is, however, possible that 
this clinical presentation may reflect 
the occurrence of an acute idiopathic 
polyneuritis,[6] possibly associated with an 
underlying predisposition to autoimmune 
diseases.[1]
The association between hyperthyroidism 
and acute flaccid areflexic neuropathy 
receives little credence in the following 
well-known clinical textbooks: Dyck and 
Thomas’ Peripheral Neuropathy[7] comments 
on its uncertain association and the difficulty 
to distinguish it from acute idiopathic 
polyneuritis; Bradley’s Neurology in Clinical 
Practice[8] refers to its association as fortuitous; 
and Williams’s Textbook of Endocrinology[9] 
and Harrison’s Internal Medicine[10] do not 
even mention the association.
Conclusion
It is important to consider the occurrence of 
other treatable causes of motor paralysis in 
patients with Graves’ disease, such as acute 
idiopathic polyneuritis presenting with a 
rapid onset of flaccid paralysis. The entity 
of Basedow paraplegia as a diagnosis, per se, 
was found to be misleading.
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Table 3. Electroneuronographic study, 25 November 2014
Motor nerve responses Sensory nerve responses
Nerve Muscle
CMAP 
amplitude
Normal 
values
Peak 
latency
SNAP 
amplitude
Normal 
value
L median APB 2.2 mV >4.0 mV Palmar 52.3 µV >50 µV
L ulnar ADM 339.0 µV >6 mV Palmar 17.9 µV >15 µV
L peroneal EDB 195.0 µV >2 mV
R peroneal EDB 92 µV >2 mV
L tibial AH No response >4 mV
R tibial AH 853 µV >4 mV
L sural Point B 14.1 µV >6 µV
L = left; R = right; CMAP = compound muscle action potential; SNAP = sensory nerve action potential. The L median, L ulnar, 
L peroneal, R peroneal and R tibial nerve distal latencies were 2.6 ms, 2.6 ms, 4.4 ms, 4.9 ms and 3.8 ms, respectively (within 
normal limits), and their conduction velocities 46.8 m/s, 56.6 m/s, 43.2 m/s, 50.0 m/s and 52.2 m/s, respectively, were also 
‘essentially’ normal. The sensory peak latencies of the R median (palmar), R ulnar (palmar) and R sural (point B) nerves were 
2.0 ms, 2.2 ms and 3.8 ms, respectively (within normal limits), and their conduction velocities 54.6 m/s, 50.6 m/s and 46.1 m/s, 
respectively, were also ‘essentially’ normal.
